RSCM
Rock Springs Capital Management Portfolio holdings
AUM
$1.6B
This Quarter Return
+7.59%
1 Year Return
+25.98%
3 Year Return
+194.74%
5 Year Return
+336.76%
10 Year Return
+2,199.29%
AUM
$2.34B
AUM Growth
+$2.34B
(+6.2%)
Cap. Flow
+$80.4M
Cap. Flow
% of AUM
3.44%
Top 10 Holdings %
Top 10 Hldgs %
23.61%
Holding
167
New
20
Increased
59
Reduced
15
Closed
19
Top Buys
| 1 |
AbbVie
ABBV
|
$56.8M |
| 2 |
Bristol-Myers Squibb
BMY
|
$38M |
| 3 |
HCA Healthcare
HCA
|
$36.9M |
| 4 |
Cencora
COR
|
$25.4M |
| 5 |
DaVita
DVA
|
$21.6M |
Top Sells
| 1 |
AAAP
Advanced Accelerator Applications S.A. American Depositary Shares
AAAP
|
$67.4M |
| 2 |
Cigna
CI
|
$65.2M |
| 3 |
Merck
MRK
|
$47.9M |
| 4 |
Johnson & Johnson
JNJ
|
$27.9M |
| 5 |
Willis Towers Watson
WTW
|
$18.5M |
Sector Composition
| 1 | Healthcare | 87.84% |
| 2 | Financials | 1.73% |
| 3 | Consumer Discretionary | 0% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
1
UnitedHealth
UNH
$281B
| $104M | 4.45% | 487,500 +500 | +0.1% | +$107K |
|
2
Intuitive Surgical
ISRG
$170B
| $59.4M | 2.53% | 143,900 | – | – |
|
|
3
AbbVie
ABBV
$372B
| $56.8M | 2.42% | +600,000 | New | +$56.8M |
|
|
ALXN
4
DELISTED
Alexion Pharmaceuticals Inc
ALXN
| $54.1M | 2.31% | 485,000 +5,000 | +1% | +$557K |
|
5
Neurocrine Biosciences
NBIX
$13.8B
| $50.3M | 2.14% | 606,200 +120,200 | +25% | +$9.97M |
|
6
Acadia Healthcare
ACHC
$2.12B
| $49.1M | 2.1% | 1,253,500 | – | – |
|
7
Collegium Pharmaceutical
COLL
$1.22B
| $49.1M | 2.09% | 1,920,000 +34,271 | +2% | +$876K |
|
8
Molina Healthcare
MOH
$9.8B
| $46.8M | 1.99% | 576,000 +9,000 | +2% | +$731K |
|
|
ONCE
9
DELISTED
Spark Therapeutics, Inc. Common Stock
ONCE
| $41.5M | 1.77% | 623,500 +8,500 | +1% | +$566K |
|
|
10
Bristol-Myers Squibb
BMY
$96B
| $41.1M | 1.75% | 650,000 +600,000 | +1,200% | +$38M |
|
|
GWPH
11
DELISTED
GW Pharmaceuticals Plc American Depositary Shares
GWPH
| $40.6M | 1.73% | 360,000 +6,000 | +2% | +$676K |
|
|
AET
12
DELISTED
Aetna Inc
AET
| $40.4M | 1.72% | 239,000 | – | – |
|
13
Madrigal Pharmaceuticals
MDGL
$9.76B
| $38M | 1.62% | 325,500 -16,500 | -5% | -$1.93M |
|
|
ONC
14
BeOne Medicines Ltd. American Depositary Shares
ONC
$36.4B
| $37.2M | 1.59% | 221,250 -44,750 | -17% | -$7.52M |
|
|
15
HCA Healthcare
HCA
$94.5B
| $36.9M | 1.57% | +380,000 | New | +$36.9M |
|
|
LOXO
16
DELISTED
Loxo Oncology, Inc
LOXO
| $36.5M | 1.56% | 316,500 +6,500 | +2% | +$750K |
|
|
RDUS
17
DELISTED
Radius Health, Inc.
RDUS
| $35.9M | 1.53% | 1,000,000 +57,000 | +6% | +$2.05M |
|
18
Pacira BioSciences
PCRX
$1.2B
| $35M | 1.49% | 1,125,000 +18,300 | +2% | +$570K |
|
|
PRAH
19
DELISTED
PRA Health Sciences, Inc.
PRAH
| $32.8M | 1.4% | 395,000 -82,500 | -17% | -$6.84M |
|
|
TSRO
20
DELISTED
TESARO, Inc.
TSRO
| $32.7M | 1.4% | 573,000 +24,500 | +4% | +$1.4M |
|
21
iRhythm Technologies
IRTC
$5.46B
| $30.1M | 1.28% | 477,500 +71,500 | +18% | +$4.5M |
|
22
Vertex Pharmaceuticals
VRTX
$100B
| $29.5M | 1.26% | 181,000 +9,750 | +6% | +$1.59M |
|
23
Stryker
SYK
$150B
| $28.6M | 1.22% | 178,000 +51,500 | +41% | +$8.29M |
|
24
Penumbra
PEN
$10.6B
| $28.1M | 1.2% | 243,000 -67,500 | -22% | -$7.81M |
|
25
Puma Biotechnology
PBYI
$254M
| $28.1M | 1.2% | 412,900 +39,400 | +11% | +$2.68M |
|